Time-Dependent Cytotoxic Properties of Terpyridine-Based Copper Complexes

Five copper complexes supported by terpyridine ligands were prepared and characterized, viz. [Cu₃Cl₄(naphtpy)₂][CuCl₂] ( 1 ), [Cu₂Cl₂(naphtpy)₂](ClO₄)₂ ( 2 ), [CuCl₂(naphtpy)]₂(MeOH)₃(H₂O) ( 3 ), [CuCl₂(Cltpy)] ( 4 ) and [Cu(Cltpy)₂](ClO₄)₂ ( 5 ); (where naphtpy stands for 4’-((naphthalen-2-yl)methoxy)-2,2′:6′,2′′-terpyridine and Cltpy for 4′-chloro-2,2′:6′,2′′-terpyridine). Their ability to interact with DNA was investigated, and their cytotoxic behaviour was examined with three cells lines, namely human ovarian carcinoma cells (A2780), their derived cisplatin-resistant line (A2780cis), and human cervix adenocarcinoma cells (HeLa). All compounds show good cytotoxic properties (especially after 72 h of incubation). Remarkably, two compounds, 4 and 5 , are still almost inactive after 24 h (particularly 4 ), but are highly active after 72 h, with IC₅₀ values in the low-micromolar to sub-micromolar range. Compounds 1 and 2 induce necrosis, whereas late apoptosis is observed with 3 – 5 , 4 exhibiting a behaviour close to that of cisplatin.     

Anticancer Potency Studies of Coordination Driven Self‐Assembled Arene–Ru‐Based Metalla‐Bowls

New tetranuclear cationic metalla‐bowls 5 – 7 with the general formula [Ru₄(p‐cymene)₄(N∩N)₂(OO∩OO)₂]⁴⁺ (N∩N=2,6‐bis(N‐(4‐pyridyl carbamoyl)pyridine, OO∩OO=2,5‐dihydroxy‐1,4‐benzoquinonato ( 5 ), OO∩OO=5,8‐dioxydo‐1,4‐naphthaquinonato ( 6 ), OO∩OO=hoxonato ( 7 )) were prepared by the reaction of the respective dinuclear ruthenium complexes 2 – 4 with a bispyridine amide donor ligand 1 in methanol in the presence of AgO₃SCF₃.These new molecular metalla‐bowls were fully characterized by analytical techniques including elemental analysis as well as ¹H and ¹³C NMR and HR‐ESI‐MS spectroscopy. The structure of metalla‐bowl 6 was determined from X‐ray crystal diffraction data. A UV/visible study was also carried out for the entire suite of new complexes. As with recent studies of similar arene–Ru complexes, the inhibition of cell growth by metalla‐bowls was established against SK‐hep‐1 (liver cancer), AGS (gastric cancer), and HCT‐15 (colorectal cancer) human cancer cell lines. Inhibition of cell growth by 6 was found to be considerably stronger against all cancer cell lines than the anticancer drugs, doxorubicin and cisplatin. In particular, in colorectal cancer cells, expression of the cancer suppressor genes APC and p53 was increased following exposure to 6 .     

Synthesis, structural characterization, and pro-apoptotic activity of 1-indanone thiosemicarbazone platinum(II) and palladium(II) complexes: potential as antileukemic agents

In the search for alternative chemotherapeutic strategies against leukemia, various 1‐indanone thiosemicarbazones, as well as eight novel platinum(II) and palladium(II) complexes, with the formula [MCl₂(HL)] and [M(HL)(L)]Cl, derived from two 1‐indanone thiosemicarbazones were synthesized and tested for antiproliferative activity against the human leukemia U937 cell line. The crystal structure of [Pt(HL1)(L1)]Cl^.2M eOH, where L1=1‐indanone thiosemicarbazone, was solved by X‐ray diffraction. Free thiosemicarbazone ligands showed no antiproliferative effect, but the corresponding platinum(II) and palladium(II) complexes inhibited cell proliferation and induced apoptosis. Platinum(II) complexes also displayed selective apoptotic activity in U937 cells but not in peripheral blood monocytes or the human hepatocellular carcinoma HepG2 cell line used to screen for potential hepatotoxicity. Present findings show that, in U937 cells, 1‐indanone thiosemicarbazones coordinated to palladium(II) were more cytotoxic than those complexed with platinum(II), although the latter were found to be more selective for leukemic cells suggesting that they are promising compounds with potential therapeutic application against hematological malignancies.     

Cytotoxic Potential of a-Azepano- and 3-Amino-3,4-SeCo-Triterpenoids

Semi-synthetic triterpenoids, holding an amino substituted seven-membered A-ring (azepano-ring), which could be synthesized from triterpenic oximes through a Beckmann type rearrangement followed by a reduction of lactame fragment, are considered to be novel promising agents exhibiting anti-microbial, alpha-glucosidase, and butyrylcholinesterase inhibitory activities. In this study, in an attempt to develop new antitumor candidates, a series of A-ring azepano- and 3-amino-3,4-seco-derivatives of betulin, oleanolic, ursolic, and glycyrrhetinic acids were evaluated for their cytotoxic activity against five human cancer cell lines and non-malignant mouse fibroblasts by means of a colorimetric sulforhodamine assay. Azepanoallobetulinic acid amide derivative 11 was the most cytotoxic compound of this series but showed little selectivity between the different human tumor cell lines. Flow cytometry experiments showed compound 11 to act mainly by apoptosis (44.3%) and late apoptosis (21.4%). The compounds were further screened at the National Cancer Institute towards a panel of 60 cancer cell lines. It was found that compounds 3, 4, 7, 8, 9, 11, 15, 16, 19, and 20 showed growth inhibitory (GI₅₀) against the most sensitive cell lines at submicromolar concentrations (0.20–0.94 μM), and their cytotoxic activity (LC₅₀) was also high (1–6 μM). Derivatives 3, 8, 11, 15, and 16 demonstrated a certain selectivity profile at GI₅₀ level from 5.16 to 9.56 towards K-562, CCRF-CEM, HL-60(TB), and RPMI-8226 (Leukemia), HT29 (Colon cancer), and OVCAR-4 (Ovarian cancer) cell lines. Selectivity indexes of azepanoerythrodiol 3 at TGI level ranged from 5.93 (CNS cancer cell lines SF-539, SNB-19 and SNB-75) to 14.89 for HCT-116 (colon cancer) with SI 9.56 at GI₅₀ level for the leukemia cell line K-562. The present study highlighted the importance of A-azepano-ring in the triterpenic core for the development of novel antitumor agents, and a future aim to increase the selectivity profile will thus lie in the area of modifications of azepano-triterpenic acids at their carboxyl group.     

Single‐Pot Ethane Carboxylation Catalyzed by New Oxorhenium(V) Complexes with N,O Ligands

The oxorhenium(V) chelates [ReOCl(N,O‐L)(PPh₃)] [N,O‐L=(OCH₂CH₂)N(CH₂CH₂OH)(CH₂COO) ( 2 ), (OCH₂CH₂)N(CH₂COO)(CH₂COOCH₃) ( 3 )] and [ReOCl₂(N,O‐L)(PPh₃)] [N,O‐L=C₅H₄N(COO‐2) ( 4 ) C₅H₃N(COOCH₃‐2)(COO‐6) ( 5 )] have been prepared by reaction of [ReOCl₃(PPh₃)₂] ( 1 ), in refluxing methanol, with N,N‐bis(2‐hydroxyethyl)glycine [bicine; N(CH₂CH₂OH)₂(CH₂COOH)], N‐(2‐hydroxyethyl)iminodiacetic acid [N(CH₂CH₂OH)(CH₂COOH)₂], picolinic acid [NC₅H₄(COOH‐2)] or 2,6‐pyridinedicarboxylic acid [NC₅H₃(COOH‐2,6)₂], respectively, with ligand esterification in the cases of 3 and 5 . All these complexes have been characterized by IR and multinuclear NMR spectroscopy, FAB⁺‐MS, elemental and X‐ray diffraction structural analyses. They act as catalysts, in a single‐pot process, for the carboxylation of ethane by CO, in the presence of potassium peroxodisulfate K₂S₂O₈, in trifluoroacetic acid (TFA), to give propionic and acetic acids, in a remarkable yield (up to ca. 30%) and under relatively mild conditions, with some advantages over the industrial processes. The picolinate complex 4 provides the most active catalyst and the carboxylation also occurs, although much less efficiently, by the TFA solvent in the absence of CO. The selectivity can be controlled by the ethane and CO pressures, propionic acid being the dominant product for pressures about ca. 7 and 4 atm, respectively (catalyst 4 ), whereas lower pressures lead mainly to acetic acid in lower yields. These reactions constitute an unprecedented use of Re complexes as catalysts in alkane functionalization.     

Five New Oxylipins from Chaenomeles sinensis

In the course of our continuing search for bioactive constituents of Korean medicinal plants, we isolated five new oxylipins, chaenomic acid A–E ( 1 – 5 ), and six known ones ( 6 – 11 ) from the twigs of Chaenomeles sinensis. The structures of the new compounds ( 1 – 5 ) were determined by spectroscopic methods, including 1D and 2D NMR (¹H and ¹³C NMR, ¹H–¹H COSY, HMQC, HMBC, and NOESY), olefin cross‐metathesis, and LC/MS analysis. The known compounds ( 6 – 11 ) were identified by comparison of their spectroscopic data and specific optical rotation with the reported data. The isolated compounds ( 1 – 11 ) were tested for their inhibitory effects on nitric oxide production in lipopolysaccharide‐activated murine microglial cells and for their cytotoxic activities against four human cancer cell lines (A549, SK‐OV‐3, A498, and HCT‐15).     

Novel Scorpionate and Pyrazole Dioxovanadium Complexes,Catalysts for Carboxylation and Peroxidative Oxidation of Alkanes

The dioxovanadium(V) complexes [VO₂(3,5‐Me₂Hpz)₃][BF₄] ( 1 ) (pz=pyrazolyl), [VO₂{SO₃C(pz)₃}] ( 2 ), [VO₂{HB(3,5‐Me₂pz)₃}] ( 3 ) and [VO₂{HC(pz)₃}][BF₄] ( 4 ), bearing pyrazole or scorpionate ligands, were obtained by reaction of triethyl vanadate [VO(OEt)₃] with hydrotris(3,5‐dimethyl‐1‐pyrazolyl)methane [HC(3,5‐Me₂pz)₃] or 3,5‐dimethylpyrazole (3,5‐Me₂Hpz; 1 ), lithium tris(1‐pyrazolyl)methanesulfonate {Li[SO₃C(pz)₃], 2 }, potassium hydrotris(3,5‐dimethyl‐1‐pyrazolyl)borate {K[HB(3,5‐Me₂pz)₃], 3 } and hydrotris(1‐pyrazolyl)methane [HC(pz)₃, 4 ], respectively. Treatment of [VO(OEt)₃] with potassium hydrotris(1‐pyrazolyl)borate {K[HB(pz)₃]} led to the mixed η³‐tris(pyrazolyl)borate and η²‐bis(pyrazolyl)borate oxovanadium(IV) complex [VO{HB(pz)₃}{H₂B(pz)₂}, 5 ]. The compounds were characterized by elemental analyses, IR, NMR and EPR spectroscopy, FAB and ESI mass spectrometry, cyclic voltammetry and, for 5 , also by single crystal X‐ray diffraction analysis. All complexes exhibit catalytic activity in the single‐pot carboxylation [in trifluoroacetic acid/potassium peroxodisulfate (CF₃COOH/K₂S₂O₈)] of gaseous alkanes (methane and ethane) to carboxylic acids (yields up to 40%, TONs up to 157) and in the peroxidative oxidation [in water/acetonitrile (H₂O/NCMe)] of liquid alkanes (cyclohexane and cyclopentane) to the corresponding alcohols and ketones (yields up to 24%, TONs up to 117), under mild conditions.     

The Tertiary Amine Nitrogen Atom of Piperazine Sulfonamides as a Novel Determinant of Potent and Selective β3‐Adrenoceptor Agonists

Novel compounds were prepared in fair to good yields as human β₃‐adrenoceptor (β₃‐AR) agonists. In particular, aryloxypropanolamines 7 a – d (EC₅₀=0.57–2.1 nM ) and arylethanolamines 12 a , b , e (EC₅₀=6.38–19.4 nM ) were designed to explore the effects of modifications at the right‐hand side of these molecules on their activity as β₃‐AR agonists. Piperidine sulfonamides 15 a – c , e – g (EC₅₀=6.1–36.2 nM ) and piperazine sulfonamide derivatives 20 – 29 (EC₅₀=1.79–49.3 nM ) were examined as compounds bearing a non‐aromatic linker on the right‐ and left‐hand sides of the molecules. Some piperazine sulfonamides were found to be potent and selective β₃‐AR agonists, even if the amine nitrogen atom is tertiary and not secondary, as is the case for all β₃‐AR agonists reported so far. (S)‐3‐{4‐{N‐{4‐{2‐[2‐Hydroxy‐3‐(4‐hydroxyphenoxy)propylamino]ethyl}phenyl}sulfamoyl}phenoxy}propanoic acid ( 7 d ; EC₅₀=0.57 nM ), (R)‐N‐{4‐[2‐(2‐hydroxy‐2‐phenylethylamino)ethyl]phenyl}‐4‐(3‐octylureido)benzenesulfonamide ( 12 e ; EC₅₀=6.38 nM ), (R)‐2‐[1‐(4‐methoxyphenylsulfonyl)piperidin‐4‐ylamino]‐1‐phenylethanol ( 15 f ; EC₅₀=6.1 nM ), and (S)‐4‐{2‐hydroxy‐3‐[4‐(4‐methoxyphenylsulfonyl)piperazin‐1‐yl]propoxy}phenol ( 25 ; EC₅₀=1.79 nM ) were found to be the most potent β₃‐AR agonists of the aryloxypropanolamine, arylethanolamine, piperidine sulfonamide, and piperazine sulfonamide classes, respectively. The two most potent compounds were identified as possible candidates for further development of β₃‐AR agonists useful in the treatment of β₃‐AR‐mediated pathological conditions.     

Versatile Phosphite Ligands Based on Silsesquioxane Backbones

Silsesquioxanes are employed as ligand backbones for the synthesis of novel phosphite compounds with 3,3′‐5,5′‐tetrakis(tert‐butyl)‐2,2′‐dioxa‐1,1′‐biphenyl substituents. Both mono‐ and bidentate phosphites are prepared in good yields. Two types of silsesquioxanes are employed as starting materials. The monophosphinite 1 and the monophosphite 2 are prepared from the thallium silsesquioxide derived from a completely condensed silsesquioxane framework (c‐C₅H₉)₇Si₇O₁₂SiOTl. The diphosphite 3 is synthesized starting with the incompletely condensed monosilylated disilanol (c‐C₅H₉)₇Si₇O₉(OSiMePh₂)(OH)₂. For monophosphite 2 , the corresponding trans‐[PtCl₂( 2 )] complex 4 is characterized by NMR spectroscopy as well as by X‐ray crystallography, as the first example of a completely condensed oxo‐functionalized silsesquioxane framework. The coordination of the bidentate ligand 3 towards Pd, Mo and Rh is studied, both by NMR spectroscopy as well as by X‐ray crystallography. Various modes of coordination are shown to be possible. The molecular structures for the complexes trans‐[PdCl₂( 3 )] ( 5 ), cis‐[Mo(CO)₄( 3 )] ( 6 ) and the dinuclear complex [{Rh(μ‐Cl)(CO)}₂(κ²‐ 3 )] ( 7 ) have been determined. In the rhodium‐catalyzed hydroformylation of 1‐octene high activities, with turnover frequencies of up to 6800 h⁻¹, are obtained with these new nanosized phosphorus ligands.     

Easily accessible oxygen‐containing derivatives of niobium pentachloride as catalytic precursors for ethylene polymerization

The low catalytic activity of NbCl₅ as an ethylene polymerization catalyst was significantly increased by the addition of a series of oxygen donors. The novel niobium derivatives NbCl₅(OPh₂) (1), NbCl₅(OEt₂) (3), NbCl₅(O?CPh₂) (5), NbCl₅(O?CHPh) (6), NbCl₅(O?CHMe) (7) and [NbCl₄(dppe)₂](NbCl₆) (18) (dppe is 1,2‐bis(diphenylphosphino)ethane) and the previously reported derivatives NbCl₅(OMePh) (2), NbCl₅(thf) (4) (thf is tetrahydrofuran), NbCl₅(O?CHOMe) (8), NbCl₅(O?CHNMe₂) (9), NbCl₅[O?C(NMe₂)₂] (10), NbCl₅(NCMe) (11), NbCl₄(κ²‐1,2‐OC₆H₄OMe) (12), NbCl₄[κ²‐O?C(Me)CH₂C(Me₂)O] (13), (14), [NbCl₄(O₂CMe)]₂ (15), NbCl₃(dme)(µ‐O)NbCl₅ (16) (dme is 1,2‐dimethoxyethane), [NbCl₄(κ²‐dmm)₂](NbCl₆) (17) (dmm is dimethylmaleate), TaCl₅(O?CMe₂) (19) and [TaCl₄(O₂CMe)]₂ (20) were tested as catalytic precursors in the ethylene polymerization reaction using AlMe₃‐depleted methylaluminoxane as co‐catalyst. Highly linear polyethylene was obtained. Compounds 1, 3, 5, 6 and 8–13 showed catalytic activities in the range 89–116 kg_polymer mol_Nb^?1 h^?1 bar^?1, i.e. comparable with the best performances reached with niobium pre‐catalysts up to now. However, the dinuclear compounds 14–16 and 18 were found to be less active, whereas17 and the tantalum derivatives 19 and 20 did not produce polymer. Relatively high molecular weights were achieved with the mononuclear compounds 1, 2, 8, 9, 10 and 12, the dinuclear 16 and the phosphine ionic 18. Copyright © 2011 Society of Chemical Industry     

Polypyridyl CoII-Curcumin Complexes as Photoactivated Anticancer and Antibacterial Agents

Four new Co^II complexes, [Co(bpy)₂(acac)]Cl ( 1 ), [Co(phen)₂(acac)]Cl ( 2 ), [Co(bpy)₂(cur)]Cl ( 3 ), [Co(phen)₂(cur)]Cl ( 4 ), where bpy=2,2’-bipyridine ( 1 and 3 ), phen=1,10-phenanthroline ( 2 and 4 ), acac = acetylacetonate ( 1 and 2 ), cur=curcumin monoanion ( 3 and 4 ) have been designed, synthesized and fully characterized. The X-ray crystal structures of 1 and 2 indicated that the CoN₄O₂ core has a distorted octahedral geometry. The photoactivity of these complexes was tuned by varying the π conjugation in the ligands. Curcumin complexes 3 and 4 had an intense absorption band near 435 nm, which made them useful as visible-light photodynamic therapy agents; they also showed fluorescence with λ_em≈565 nm. This fluorescence was useful for studying their intracellular uptake and localization in MCF-7 breast cancer cells. The acetylacetonate complexes ( 1 and 2 ) were used as control complexes to understand the role of curcumin. The white-light-triggered anticancer profiles of the cytosol targeting complexes 3 and 4 were investigated in detail. These non-dark toxic complexes displayed significant apoptotic photo-cytotoxicity (under visible light) against MCF-7 cells through ROS generation. The control complexes 1 and 2 did not induce significant cell death in the light or dark. Interestingly, 1-4 produced a remarkable antibacterial response upon light exposure. Overall, the reported results here can increase the boundary of the Co^II-based anticancer and antibacterial drug development.     

Bis(dipyridophenazine)(2‐(2′‐pyridyl)pyrimidine‐4‐carboxylic acid)ruthenium(II) Hexafluorophosphate: A Lesson in Stubbornness

Ruthenium complexes are currently considered to be among the most promising alternatives to platinum anticancer drugs. In this work, thirteen structural analogues and organelle/receptor‐targeting peptide bioconjugates of a cytotoxic bis(dppz)‐Ru^II complex [Ru(dppz)₂(CppH)](PF₆)₂ ( 1 ) were prepared, characterized, and assessed for their cytotoxicity and cellular localization (CppH=2‐(2′‐pyridyl)pyrimidine‐4‐carboxylic acid; dppz=dipyrido[3,2‐a:2′,3′‐c]phenazine). It was observed that structural modifications (lipophilicity, charge, and size‐based) result in the cytotoxic potency of 1 being compromised. Confocal microscopy studies revealed that unlike 1 , the screened complexes/bioconjugates do not have a preferential accumulation in mitochondria. The results of this important structure–activity relationship strongly support our initial hypothesis that accumulation in mitochondria is crucial for 1 to exert its cytotoxic action.     

Cell‐Selective,Apoptosis‐inducing Rhodium(III) Crown Thiaether Complexes

Half‐sandwich rhodium(III) polypyridyl (pp) complexes with the metal atom capped by the facial crown thiaether 1,4,7‐trithiacyclononane [9]aneS₃ represent a promising class of apoptosis‐inducing potent cytostatic agents. The necrotic damage caused by the complexes is negligible. In vitro cytotoxicity assays with the human cancer cell lines MCF‐7 and HT‐29 and immortalized HEK‐293 cells indicate that the dicationic κ²N(imino) complexes [([9]aneS₃)RhCl(pp)]²⁺ are much more active than monocationic complexes [([9]aneS₃)RhCl₂(L)]⁺ (L=imidazole, CH₃CN). Whereas the κ²N(amino) complex [([9]aneS₃)RhCl(piperazine)]²⁺ is inactive, replacing piperazine with the structurally analogous κ²S (thiaether) ligand 1,4‐dithiane restores cytotoxicity as evidenced by IC₅₀ values in the range 8.1‐11.6 μM . Spectroscopic (CD, UV/Vis, NOESY) and viscosity measurements indicate that the active dppz complex 8 (IC₅₀ values: 4.7–8.9 μM ) exhibits strong intercalative binding towards DNA whereas the even more potent bipyrimidine complex 9 (IC₅₀ values: 0.6–1.9 μM ) causes no alteration of the duplex B conformation. Weaker intercalative binding is observed for the dpq complex 7 . A comparative annexin V–propidium iodide binding assay with lymphoma (BJAB) cells and healthy leukocytes demonstrates that the cytotoxic activity of complex 8 and particularly complex 9 is highly selective towards the malignant cells.     

The synthesis,spectroscopic investigation,crystal and molecular structure of [ReCl3(MeCN)(dppe)] complex

The [ReOCl₃(dppe)] complex reacts with acetonitrile in the presence of excess of triphenylphosphine to give a new monomeric nitrile rhenium(III) complex – [ReCl₃(MeCN)(dppe)] (1). This paper presents spectroscopic characterization, magnetochemical measurements, crystal and molecular structure for 1.     

Synthesis of Isocryptolepine-Triazole Adducts and Evaluation of Their Cytotoxic Activity

Eighteen hybrid compounds between 8-bromo-2-fluoro-isocryptolepine ( 4 ) and 1,2,3-triazole were synthesized via azide rearrangement-annulation reaction. Compound 4 underwent regioselective N-propargylation and click reaction to form 8-bromo-2-fluoro-isocryptolepine-triazole hybrids 11 which were evaluated for cytotoxic activity. Compound 11 c containing 1-anisyltriazole was the most effective in inhibiting HepG2, HuCCA-1 and A549 cell lines (IC₅₀ values of 1.65–3.07 μM) while compounds 11 a (1-phenyltriazole), 11 j (1-para-CF₃-benzyltriazole) and 11 l (1-meta-Cl-benzyltriazole) were potent inhibitors of HuCCA-1, HepG2 and A549 cell lines, respectively. Moreover, 11 l showed the lowest cytotoxicity to normal human kidney cell line. Compounds 11 c and 11 l provided improvement of cytotoxic activity over 4 . Compounds 4 , 11 c and 11 l were selected to investigate their mechanisms of action. The results showed that 4 could induce G2/M cell cycle arrest and was involved in the upregulation of p53 and p21 proteins. However, the mechanisms of growth inhibition by 11 c and 11 l were associated with G0/G1 cell cycle arrest and mediated by induction of oxidative stress.     

6,7‐Dimethoxy‐2‐{2‐[4‐(1H‐1,2,3‐triazol‐1‐yl)phenyl]ethyl}‐1,2,3,4‐tetrahydroisoquinolines as Superior Reversal Agents for P‐Glycoprotein‐Mediated Multidrug Resistance

P‐glycoprotein (P‐gp)‐mediated multidrug resistance (MDR) is a major obstacle for successful cancer chemotherapy. Based on our previous study, 17 novel compounds with the 6,7‐dimethoxy‐2‐{2‐[4‐(1H‐1,2,3‐triazol‐1‐yl)phenyl]ethyl}‐1,2,3,4‐tetrahydroisoquinoline scaffold were designed and synthesized. Among them, 2‐[(1‐{4‐[2‐(6,7‐dimethoxy‐3,4‐dihydroisoquinolin‐2(1H)‐yl)ethyl]phenyl}‐1H‐1,2,3‐triazol‐4‐yl)methoxy]‐N‐(p‐tolyl)benzamide (compound 7 h ) was identified as a potent modulator of P‐gp‐mediated MDR, with high potency (EC₅₀=127.5±9.1 nM ), low cytotoxicity (TI>784.3), and long duration (>24 h) in reversing doxorubicin (DOX) resistance in K562/A02 cells. Compound 7 h also enhanced the effects of other MDR‐related cytotoxic agents (paclitaxel, vinblastine, and daunorubicin), increased the accumulation of DOX and blocked P‐gp‐mediated rhodamine 123 efflux function in K562/A02 MDR cells. Moreover, 7 h did not have any effect on cytochrome (CYP3A4) activity. These results indicate that 7 h is a relatively safe modulator of P‐gp‐mediated MDR that has good potential for further development.     

Self-Recognition of 3D Porous Frameworks: Fourfold Diamondoid or Threefold Cuboidal Interpenetrating Nets Formed by Varying Pillar Motifs

Compound [Ni(2,6-ndc)(bpe)(H₂O)] _n (1) was prepared by the hydrothermal reaction of 2,6-naphthalenedicarboxylic acid (2,6-H₂ndc) and trans-1,2-bis(4-pyridyl)ethylene (bpe) with Ni(NO₃)₂·6H₂O under alkaline (NaOH) conditions. Treatment of 2,6-H₂ndc, 4,4′-bipyridine (4,4′-bpy) with M(NO₃)₂·6H₂O (M = Ni or Co) under similar conditions afforded compounds [Ni₂(2,6-ndc)₂(4,4′-bpy)] _n (2) and [Co₂(2,6-ndc)₂(4,4′-bpy)] _n (3), respectively. A single-crystal X-ray diffraction study revealed that compound 1 adopts a 3D fourfold interpenetrating diamondoid network stabilized by inter-net OH···O hydrogen bonds. The anionic 2,6-ndc ligand presents two different bonding characteristics, bis(monodentate) and bis(chelating bidentate) modes. A solid-state structural analysis revealed that compounds 2 and 3 are isomorphous and isostructural. Both present a 3D threefold interpenetrating cuboidal framework, consisting of a 2D (4,4)-net of interconnected [M ₂(O₂C)₄] (M = Ni, Co) paddle-wheel dinuclear units, and pillared by 4,4′-bpy ligands. The degree of interpenetration of these compounds could be adjusted successfully by varying only the organic pillar motifs.     

Anticancer Gold(III) Peptidomimetics: From Synthesis to in vitro and ex vivo Biological Evaluations

Five new Au^III‐peptidodithiocarbamato complexes of the type [Au^IIIBr₂(dtc‐AA₁‐AA₂‐OR] (in which AA₁=N‐methylglycine (Sar), l /d ‐Pro; AA₂=l /d ‐Ala, α‐aminoisobutyric acid (Aib); R=OtBu, triethylene glycol methyl ether), differing with regard to the amino acid sequence and/or the chiral amino acid configuration, were designed to enhance tumor selectivity and bioavailability. The gold(III)‐based moiety was functionalized to exploit the targeting properties of the peptidomimetic ligand toward two peptide transporters (namely PEPT1 and PEPT2), which are upregulated in several tumor cells. The compounds were synthesized and fully characterized, mainly by means of elemental analysis, one‐ and two‐dimensional NMR spectroscopy, FT‐IR, and UV/Vis spectrophotometry. The crystal structures of three compounds were also solved by X‐ray diffraction. In vitro cytotoxicity studies using a panel of human tumor cell lines (A549 [non‐small‐cell lung carcinoma], MCF‐7 [breast cancer], A2780 [ovarian carcinoma], H1975 [non‐small‐cell lung carcinoma], H460 [large‐cell lung carcinoma], and A431 [human epidermoid carcinoma]) showed the dtc‐Pro‐Aib‐OtBu derivative to be very effective, with GI₅₀ values much lower than those of cisplatin. This complex was thus selected for evaluating stability under physiological conditions and possible interactions with serum albumin, as well in PARP‐1 enzyme inhibition assays and preliminary ex vivo toxicity experiments on healthy rat tissues.     

[Carboxyl‐11C]Labelling of Four High‐Affinity cPLA2α Inhibitors and Their Evaluation as Radioligands in Mice by Positron Emission Tomography

Cytosolic phospholipase A2α (cPLA2α) may play a critical role in neuropsychiatric and neurodegenerative disorders associated with oxidative stress and neuroinflammation. An effective PET radioligand for imaging cPLA2α in living brain might prove useful for biomedical research, especially on neuroinflammation. We selected four high‐affinity (IC₅₀ 2.1–12 nm ) indole‐5‐carboxylic acid‐based inhibitors of cPLA2α, namely 3‐isobutyryl‐1‐(2‐oxo‐3‐(4‐phenoxyphenoxy)propyl)‐1H‐indole‐5‐carboxylic acid ( 1 ); 3‐acetyl‐1‐(2‐oxo‐3‐(4‐(4‐(trifluoromethyl)phenoxy)phenoxy)propyl)‐1H‐indole‐5‐carboxylic acid ( 2 ); 3‐(3‐methyl‐1,2,4‐oxadiazol‐5‐yl)‐1‐(2‐oxo‐3‐(4‐phenoxyphenoxy)propyl)‐1H‐indole‐5‐carboxylic acid ( 3 ); and 3‐(3‐methyl‐1,2,4‐oxadiazol‐5‐yl)‐1‐(3‐(4‐octylphenoxy)‐2‐oxopropyl)‐1H‐indole‐5‐carboxylic acid ( 4 ), for labelling in carboxyl position with carbon‐11 (t_1/2=20.4 min) to provide candidate PET radioligands for imaging brain cPLA2α. Compounds [¹¹C] 1 – 4 were obtained for intravenous injection in adequate overall yields (1.1–5.5 %) from cyclotron‐produced [¹¹C]carbon dioxide and with moderate molar activities (70–141 GBq μmol^?1) through the use of Pd⁰‐mediated [¹¹C]carbon monoxide insertion on iodo precursors. Measured logD_7.4 values were within a narrow moderate range (1.9–2.4). After intravenous injection of [¹¹C] 1 – 4 in mice, radioactivity uptakes in brain peaked at low values (≤0.8 SUV) and decreased by about 90 % over 15 min. Pretreatments of the mice with high doses of the corresponding non‐radioactive ligands did not alter brain time–activity curves. Brain uptakes of radioactivity after administration of [¹¹C] 1 to wild‐type and P‐gp/BCRP dual knock‐out mice were similar (peak 0.4 vs. 0.5 SUV), indicating that [¹¹C] 1 and others in this structural class, are not substrates for efflux transporters.     

Synthesis,Biological Evaluation of 1,1‐Diarylethylenes as a Novel Class of Antimitotic Agents

The cytotoxic activities of 23 new isocombretastatin A derivatives with modifications on the B‐ring were investigated. Several compounds exhibited excellent antiproliferative activity at nanomolar concentrations against a panel of human cancer cell lines. Compounds isoFCA‐4 ( 2 e ), isoCA‐4 ( 2 k ) and isoNH₂CA‐4 ( 2 s ) were the most cytotoxic, and strongly inhibited tubulin polymerization with IC₅₀ values of 4, 2 and 1.5 μM , respectively. These derivatives were found to be 10‐fold more active than phenstatin and colchicine with respect to growth inhibition but displayed similar activities as tubulin polymerization inhibitors. In addition, cell cycle arrest in the G₂/M phase and subsequent apoptosis was observed in three cancer cell lines when treated with these compounds. The disruptive effect of 2 e , 2 k and 2 s on the vessel‐like structures formed by human umbilical vein endothelial cells (HUVEC) suggest that these compounds may act as vascular disrupting agents. Both compounds 2 k and 2 s have the potential for further prodrug modification and development as vascular disrupting agents for treatment of solid tumors.